TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study.

Jonathan Strosberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.